Medicine

Guide

19 Feb 2019

This quick guide provides an overview of how therapeutic goods are approved, how their supply is regulated, and how they are monitored for safety in Australia.

Conference paper

3 Sep 2018

Providing patients with information about their medicines is an essential part of a therapy. This paper discusses six perspectives for the design of information for patients.

Report

4 May 2018

This final report provides the review panel’s recommendations on consumers' continued access to affordable medicines, future remuneration, regulation and other arrangements that apply to pharmacies and wholesalers for the dispensing and supply of medicines and other services provided under the Pharmaceutical Benefits Scheme (PBS).

Report

31 Jan 2018

This report sets out the status of precision medicine, where it is likely to go over the next five to ten years, opportunities on which to capitalise, challenges for which to prepare and the considerable potential of precision medicine to enhance medical practice and transform...

Report

23 Jun 2017

The vision underpinning this interim report is for an integrated and sustainable community pharmacy sector, which is adaptive to the inevitable changes in health care given Australia’s ageing population, rapid advances in technology and ongoing Pharmaceutical Benefits Scheme (PBS) reform.

Report

7 Jun 2017

This review identifies factors that influence policy change, explores international policy developments, and calls out potential opportunities for further reform of access to cancer treatments.

Article

29 Jan 2017

Medications that trigger sleepwalking may inadvertently put the patient at risk of injury to themselves and/or others, and contribute to poor treatment adherence. The aim of this study was to systematically review the literature to identify drugs that may increase the risk of sleepwalking.

Journal article

14 Nov 2016

Canada was one of the first countries worldwide to legalize the use of cannabis for therapeutic purposes. The federally regulated cannabis access program has not had the support of medical regulatory authorities. Recent changes to federal rules are controversial in imposing responsibility on physicians to...

Discussion paper

27 Jul 2016

The Review of Pharmacy Remuneration and Regulation (the Review) forms a key component of the Sixth Community Pharmacy Agreement (6CPA) made between the Commonwealth and the Pharmacy Guild of Australia (the Guild). As outlined in the 6CPA, the Review is based on specific Terms of...

Report

Strategy

12 Jul 2016

Victoria’s Health and Medical Research Strategy 2016–2020 (the strategy) is designed to embed health and medical research into the Victorian health system and accelerate the translation of research into clinical practice. The vision of this strategy is to position Victoria as a global leader in...

Report

19 May 2016

Concerned about the rising levels of drug resistance whereby microbes evolve to become immune to a known drugs, the UK Prime Minister asked economist Jim O’Neill to analyse this global problem of antimicrobial resistance (AMR) and propose concrete actions to tackle it internationally. In July...

Commentary

Article

13 Apr 2016

Working out whether a treatment works, and for how many people, is trickier than it sounds. Here’s how you should go about doing it

WHEN I had been a doctor for ten years, I enrolled in a postgraduate course in epidemiology and biostatistics....

Report

8 Apr 2016

About This Serious Transfusion Incident Report (STIR) 2013-14 summary captures two main categories of incidents — clinical and procedural.

Report

2 Mar 2016

Snake venom may hold key to breaking down plaques that cause Alzheimer’s disease, this report shows.

Abstract Neprilysin (NEP) and endothelin converting enzyme-1 (ECE-1) are two enzymes that degrade amyloid beta in the brain. Currently there are no molecules to stimulate the activity...

Journal article

1 Jan 2016

Complementary medicines have associated risks which include toxic heavy metal(loid) and pesticide contamination. The objective of this study was to examine the speciation and bioavailability of lead (Pb) in selected complementary medicines. Six herbal and six ayurvedic medicines were analysed for: (i) total heavy metal(loid)...

Commentary

13 Nov 2015

We are making progress in understanding some of the most elusive and debilitating conditions of modern times – the mental illnesses that account for almost a quarter of the health-related disability worldwide.

Turning technological breakthroughs such as brain imaging, genetic profiling and digital communication...

Report

29 Oct 2015

Recent reports in both the general and scientific media show there is increasing concern within the biomedical research community about the lack of reproducibility of key research findings. If too many results are irreproducible, it could hinder scientific progress, delay translation into clinical applications and...

Report

6 Oct 2015

This report completes the Victorian Law Reform Commission’s review of law reform options that would allow people in Victoria to be treated with medicinal cannabis in exceptional circumstances.

Introduction

This report completes the Victorian Law Reform Commission’s review of law reform options...

Report

Precision Medicine Initiative (PMI) Working Group Report to the Advisory Committee to the Director, NIH
17 Sep 2015

Final report and presentation also included.

Background

On January 20, 2015, President Obama launched a new U.S. initiative, the Precision Medicine Initiative (PMI), to accelerate our understanding of individual variability and its effect on disease onset, progression, prevention, and treatment. There are...

Commentary

Article

24 Aug 2015

While people in the affluent world are living longer and healthier lives than ever before, they have become more and more fearful and worried about their health. Iona Heath untangles the distinct yet overlapping fears of patients, doctors, bureaucrats, politicians and society at large....

Overview

 

Items: 63